Aclaris Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
ACRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
701 Lee Road, Suite 103, Wayne, PA

Insiders trading volume in the past year

Aclaris Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden Michael Leonard 10%+ Owner $17.7M Aug 2, 2024
Neal Walker CEO, Director $2.06M May 1, 2025
Anand Mehra Director $1.1M +$1.5M Jun 5, 2025
Andrew N. Schiff Director $691K Jun 5, 2025
Joseph Monahan Chief Scientific Officer $551K Mar 1, 2025
James Loerop Chief Business Officer $463K Feb 1, 2025
Frank Ruffo Chief Financial Officer $229K Mar 10, 2022
Kevin Balthaser Chief Financial Officer $189K Mar 1, 2025
Hugh M. Davis President and COO, Director $185K Feb 3, 2025
Kamil Ali-Jackson Chief Legal Officer $168K Jan 3, 2022
David N. Gordon Chief Medical Officer $161K Jul 13, 2021
Douglas J. Manion Pres and CEO, Director $129K Jan 1, 2024
Christopher P. Molineaux Director $93.6K Jun 5, 2025
Gail Cawkwell Chief Medical Officer $57.3K Jul 1, 2023
William D. Humphries Director $56.2K Jun 5, 2025
Andrew Kenneth William Powell Director $42.2K Jun 1, 2024
Maxine Gowen Director $38.2K Jun 5, 2025
Bryan M. Reasons Director $36.2K Jun 1, 2024
Vincent Milano Director $31.4K Jun 5, 2025
Foresite Capital Management III, LLC 10%+ Owner $8.69K Nov 1, 2021
Biosion, Inc. 10%+ Owner Nov 18, 2024
Jesse Wayne Hall Chief Medical Officer May 1, 2025
Roland Wilhelm Kolbeck Chief Scientific Officer Aug 1, 2025

Recent Insider Transactions by Companies or Individuals for Aclaris Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.